Skip to main content
CGC
NASDAQ Life Sciences

Canopy Growth Changes Auditors Amidst Ongoing Financial Reporting Challenges

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.97
Mkt Cap
$432.178M
52W Low
$0.844
52W High
$2.38
52W Position info
15% above low
Off High info
59% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CGC is trading near its 52-week low of $0.844 (15% above the low).

Summary

Canopy Growth announced the resignation of its independent auditor, PKF O'Connor Davies, LLP, citing strategic changes in the firm's cannabis sector services, and appointed MNP LLP as its new auditor. This follows recent restatements and an adverse opinion on internal controls.


Key Events · Corporate Governance and Compliance · CGC

  • Auditor Resignation

    PKF O'Connor Davies, LLP resigned as Canopy Growth's independent registered public accounting firm, effective August 7, 2026.

  • Reason for Resignation

    The firm cited "strategic changes in the desire of the firm to provide services to the cannabis sector" as the reason for its resignation.

  • Adverse Opinion on Internal Controls

    PKFOD's prior audit report for March 31, 2026, included an adverse opinion on the company's internal control over financial reporting due to a material weakness.

  • New Auditor Appointed

    MNP LLP, a nationally recognized auditing firm, was engaged as the successor independent registered public accounting firm for the fiscal year ending March 31, 2027.


Analysis · CGC · Life Sciences

This auditor change is notable given Canopy Growth's recent history of financial reporting issues, including restatements and an adverse opinion on internal controls over financial reporting from the resigning auditor. While the resignation was attributed to the auditor's strategic shift away from the cannabis sector rather than disagreements with the company, the timing adds to the narrative of scrutiny around the company's financial statements. The engagement of a new auditor, MNP LLP, is a necessary step to ensure continued compliance and auditing oversight.

At the time of this filing, CGC was trading at $0.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $432.2M. The 52-week trading range was $0.84 to $2.38. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CGC - Latest Insights

CGC
Aug 07, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9674
Real-time Price: $0.9699 info
Change: +$0.0025 (+0.26%) info
Market Cap: $432.178M info
CGC
Aug 07, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.960
Real-time Price: $0.9699 info
Change: +$0.0099 (+1%) info
Market Cap: $432.178M info
CGC
Aug 07, 2026, 6:45 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.965
Real-time Price: $0.9699 info
Change: +$0.0049 (+0.51%) info
Market Cap: $432.178M info
CGC
Jul 17, 2026, 4:25 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.9549
Real-time Price: $0.9699 info
Change: +$0.015 (+2%) info
Market Cap: $432.178M info
CGC
Jun 15, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.965
Real-time Price: $0.9699 info
Change: +$0.0049 (+0.51%) info
Market Cap: $432.178M info